3D Cell Culture Market Overview:
The global 3D cell culture market size was evaluated at $1,234.86 million in 2019, and is estimated to garner $3,721.68 million by 2027, registering a CAGR of 16.3% during the forecast period.
A 3D cell culture is an in-vitro technique wherein the cells can grow in an artificially created environment. These environments closely resemble the architecture and functioning of the native tissue. 3D cell culture technique helps stimulate cell differentiation, proliferation, and migration by interacting with their three-dimensional surroundings as they would in the in-vivo environment. As 3D cell cultures can mimic the structure, activity, and microenvironment of the in-vivo tissues, this technique has varied applications in the fields of drug screening, regenerative medicine, stem cell therapies, cancer research and cell biology. The extracellular matrix in 3D cell cultures enables cell–cell communication by direct contact as in in-vivo environment by secreting cytokines and trophic factors. These factors are changed in a 2D environment that can significantly affect the cell–cell communication, which in turn can alter the cell morphology and proliferation. As 2D cultures cannot recapitulate the architecture and complex cellular matrices as in 3D cultures, this technique is gaining popularity in healthcare research sector. In addition, 3D cell cultures can provide results with improved efficiency and reduce the cost of overall R&D process.
COVID-19 Impact
The COVID-19 pandemic has resulted in nationwide lockdowns, thereby impacting every industry vertical. Likewise, the 3D cell culture market is also affected by the pandemic. The 3D cell culture industry is currently facing newer challenges to cope up with the demand and supply of 3D cell culture components owing to the COVID-19 pandemic. In addition, inconsistent and interrupted supply chain activities and availability of human resources are expected to impact the market growth. On the contrary, surge in research practices for developing novel therapies against COVID-19 is serving as a huge opportunity for the key market players. Research associated with stem cell therapies and regenerative medicine has shown promising results for treating the COVID-19 disease, thus, this is expected to compensate the deleterious impact caused by lockdowns globally. Thus, the overall COVID-19 impact is anticipated to remain moderate for the prominent players in the 3D cell culture market.
Product Segment Review
Based on product, the 3D cell culture market can be categorized into scaffold-based platforms, scaffold-free platforms, gels, bioreactors, microchips, and services. Scaffold-based platforms are used to alter the cell culture procedure by providing a surface on which the cells can easily impart 3D growth. Scaffolds are used in drug discovery and cell expansion, owing to the availability of a variety of materials and structural choices. In addition, there are other advantages related to the use of scaffold-based platforms such as ease of imaging and simple assay protocol. Moreover, the mechanical and biochemical properties of the scaffold can easily be modified as per the need of the application. Thus, this segment is expected to dominate the product segment throughout the forecast period as there is a high demand for scaffold-based platforms for creating 3D cell cultures. Nevertheless, scaffold-based platforms can adsorb test compounds, limit downstream endpoints for analysis, and introduce different biological substances, thereby obstructing the segment growth.
Application Segment Review
Based on application, the 3D cell culture market is segmented into cancer research, stem cell research, drug discovery, and regenerative medicine. Cancer research segment is anticipated to be the largest growing segment over the analysis period. This is majorly attributed to the advantages offered by 3D cell culture in cancer research, these include ease of altering cell proliferation and morphology, revealing realistic drug response, capturing phenotypic heterogeneity, allowing experimental manipulation in gene expression & cell behavior and representing the tumor microenvironment. Preclinical studies that utilize the benefits of 3D cell culture early on can critically improvise the understanding of cancer biology. These include elimination of poor drug candidates and identification of physiologically relevant targets that were previously inaccessible in 2D cultures. This can largely contribute toward the segment growth.
End User Segment Review
Based on end users, the global 3D cell culture market is segmented into biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes. The academic institutes segment held a dominant position in the end user segment throughout the analysis period. This growth is due to rise in collaborations between several companies with research institutes and clinical laboratories owing to the rise in demand of 3D cell cultures for various healthcare applications. For instance, Procter & Gamble (P&G) and Durham University based in the UK have collaborated for engineering 3D skin substitutes with the help of tissue-mimetic 2D platforms for studying the process of ageing in-vitro. In addition, many academic institutes have focused their R&D activities toward 3D culture models for developing novel approaches for treating different medical conditions. This surge in research activities across academic institutes and universities is predicted to propel the growth of the segment over the analysis period.
Region segment review
North America is expected to maintain its dominance during the forecast period due to the presence of several pharmaceutical and biotechnology companies that use 3D culture technology in collaboration with research institutes and clinical laboratories for developing regenerative medicines and drug discovery & development. Furthermore, rise in demand for organ transplantation and upsurge in R&D activities focused on technologically advanced solutions is predicted to fuel the adoption of 3D cell culture practices in the region. In addition, a surge in incidences of cancer has led the government to increase the funding and grants for R&D in the field of cancer, which may have a positive impact on the 3D cell culture market growth. Moreover, the strategic expansion of biotechnological and pharmaceutical companies has led to launch of advanced products, which are expected to augment the market growth in coming years.
Key players profiled in this report include 3D Biotek, LLC, Advanced Biomatrix, Inc., Avantor, Inc., Becton, Dickinson, and Company, Corning Incorporated, InSphero AG, Lonza Group Ltd., Merck & Co., Inc., Synthecon, Incorporated, and Thermo Fisher Scientific Inc.
Key Benefits For Stakeholders
Key Market Segments
By Product
By Application
By End User
By Region
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Patent analysis
3.3.1.Patent analysis, by year
3.3.2.Patent analysis, by country
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Advantages of 3D culture techniques over 2D techniques
3.4.1.2.Growth in investments toward R&D activities
3.4.1.3.Shift in preference toward 3D cell cultures for cancer research
3.4.1.4.Upsurge in demand for organ transplantation
3.4.2.Restraints
3.4.2.1.Higher implementation costs
3.4.2.2.Irregularity in 3D cell culture outcomes
3.4.3.Opportunity
3.4.3.1.Technological advancements
3.5.COVID-19 Impact analysis
CHAPTER 4:3D CELL CULTURE MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Scaffold-based platform
4.2.1.Key market trends and growth opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country
4.2.4.Scaffold-based platform market, by type
4.2.4.1.Macro-Porous Scaffolds
4.2.4.1.1.Market size and forecast
4.2.4.2.Micro-Porous Scaffolds
4.2.4.2.1.Market size and forecast
4.2.4.3.Nano-Porous Scaffolds
4.2.4.3.1.Market size and forecast
4.2.4.4.Solid Scaffolds
4.2.4.4.1.Market size and forecast
4.3.Scaffold-Free Platform
4.3.1.Key market trends and growth opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.4.Gels
4.4.1.Key market trends and growth opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
4.5.Bioreactors
4.5.1.Key market trends and growth opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country
4.6.Microchips
4.6.1.Key market trends and growth opportunities
4.6.2.Market size and forecast
4.6.3.Market analysis, by country
4.7.Services
4.7.1.Key market trends and growth opportunities
4.7.2.Market size and forecast
4.7.3.Market analysis, by country
CHAPTER 5:3D CELL CULTURE MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Cancer research
5.2.1.Market size and forecast
5.2.2.Market analysis, by country
5.3.Stem cell research
5.3.1.Market size and forecast
5.3.2.Market analysis, by country
5.4.Drug discovery
5.4.1.Market size and forecast
5.4.2.Market analysis, by country
5.5.Regenerative medicine
5.5.1.Market size and forecast
5.5.2.Market analysis, by country
CHAPTER 6:3D CELL CULTURE MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Biotechnology & pharmaceutical companies
6.2.1.Market size and forecast
6.2.2.Market analysis, by country
6.3.Contract research laboratories
6.3.1.Market size and forecast
6.3.2.Market analysis, by country
6.4.Academic institutes
6.4.1.Market size and forecast
6.4.2.Market analysis, by country
CHAPTER 7:3D CELL CULTURE MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends and opportunities
7.2.2.Market size and forecast, by country
7.2.3.North America 3D cell culture market by product
7.2.4.North America 3D cell culture market by application
7.2.5.North America 3D cell culture market by end user
7.2.6.U.S.
7.2.6.1.U.S. 3D cell culture market by product
7.2.6.2.U.S. 3D cell culture market by application
7.2.6.3.U.S. 3D cell culture market by end user
7.2.7.Canada
7.2.7.1.Canada 3D cell culture market by product
7.2.7.2.Canada 3D cell culture market by application
7.2.7.3.Canada 3D cell culture market by end user
7.2.8.Mexico
7.2.8.1.Mexico 3D cell culture market by product
7.2.8.2.Mexico 3D cell culture market by application
7.2.8.3.Mexico 3D cell culture market by end user
7.3.Europe
7.3.1.Key market trends and opportunities
7.3.2.Market size and forecast, by country
7.3.3.Europe 3D cell culture market by product
7.3.4.Europe 3D cell culture market by application
7.3.5.Europe 3D cell culture market by end user
7.3.6.Germany
7.3.6.1.Germany 3D cell culture market by product
7.3.6.2.Germany 3D cell culture market by application
7.3.6.3.Germany 3D cell culture market by end user
7.3.7.France
7.3.7.1.France 3D cell culture market by product
7.3.7.2.France 3D cell culture market by application
7.3.7.3.France 3D cell culture market by end user
7.3.8.UK
7.3.8.1.UK 3D cell culture market by product
7.3.8.2.UK 3D cell culture market by application
7.3.8.3.UK 3D cell culture market by end user
7.3.9.Rest of Europe
7.3.9.1.Rest of Europe 3D cell culture market by product
7.3.9.2.Rest of Europe 3D cell culture market by application
7.3.9.3.Rest of Europe 3D cell culture market by end user
7.4.Asia-Pacific
7.4.1.Key market trends and opportunities
7.4.2.Market size and forecast, by country
7.4.3.Asia-Pacific 3D cell culture market by product
7.4.4.Asia-Pacific 3D cell culture market by application
7.4.5.Asia-Pacific 3D cell culture market by end user
7.4.6.Japan
7.4.6.1.Japan 3D cell culture market by product
7.4.6.2.Japan 3D cell culture market by application
7.4.6.3.Japan 3D cell culture market by end user
7.4.7.China
7.4.7.1.China 3D cell culture market by product
7.4.7.2.China 3D cell culture market by application
7.4.7.3.China 3D cell culture market by end user
7.4.8.India
7.4.8.1.India 3D cell culture market by product
7.4.8.2.India 3D cell culture market by application
7.4.8.3.India 3D cell culture market by end user
7.4.9.Australia
7.4.9.1.Australia 3D cell culture market by product
7.4.9.2.Australia 3D cell culture market by application
7.4.9.3.Australia 3D cell culture market by end user
7.4.10.Rest of Asia-Pacific
7.4.10.1.Rest of Asia-Pacific 3D cell culture market by product
7.4.10.2.Rest of Asia-Pacific 3D cell culture market by application
7.4.10.3.Rest of Asia-Pacific 3D cell culture market by end user
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.Market size and forecast, by country
7.5.3.LAMEA 3D cell culture market by product
7.5.4.LAMEA 3D cell culture market by application
7.5.5.LAMEA 3D cell culture market by end user
7.5.6.Brazil
7.5.6.1.Brazil 3D cell culture market by product
7.5.6.2.Brazil 3D cell culture market by application
7.5.6.3.Brazil 3D cell culture market by end user
7.5.7.Saudi Arabia
7.5.7.1.Saudi Arabia 3D cell culture market by product
7.5.7.2.Saudi Arabia 3D cell culture market by application
7.5.7.3.Saudi Arabia 3D cell culture market by end user
7.5.8.South Africa
7.5.8.1.South Africa 3D cell culture market by product
7.5.8.2.South Africa 3D cell culture market by application
7.5.8.3.South Africa 3D cell culture market by end user
7.5.9.Rest of LAMEA
7.5.9.1.Rest of LAMEA 3D cell culture market by product
7.5.9.2.Rest of LAMEA 3D cell culture market by application
7.5.9.3.Rest of LAMEA 3D cell culture market by end user
CHAPTER 8:COMPANY PROFILES
8.1.3D BIOTEK LLC
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Business performance
8.2.ADVANCED BIOMATRIX, INC.
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Business performance
8.2.5.Key strategic moves and developments
8.3.AVANTOR, INC.
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Business performance
8.4.BECTON, DICKINSON AND COMPANY
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Business performance
8.5.CORNING INCORPORATED
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Business performance
8.5.5.Key strategic moves and developments
8.6.INSPHERO AG
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Business performance
8.6.5.Key strategic moves and developments
8.7.LONZA GROUP LTD.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Business performance
8.7.5.Key strategic moves and developments
8.8.MERCK & CO., INC.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Business performance
8.9.SYNTHECON, INCORPORATED
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Business performance
8.10.THERMO FISHER SCIENTIFIC INC.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Business performance
LIST OF TABLES
TABLE 01.2D CELL CULTURES VS 3D CELL CULTURES
TABLE 02.ORGAN DONATION RATE, 2018
TABLE 03.3D CELL CULTURE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 04.3D CELL CULTURE MARKET FOR SCAFFOLD-BASED PLATFORM, BY REGION, 2019–2027 ($MILLION)
TABLE 05.SCAFFOLD-BASED PLATFORM SEGMENT, BY TYPE, 2019–2027 ($MILLION)
TABLE 06.3D CELL CULTURE MARKET FOR SCAFFOLD-FREE PLATFORM, BY REGION, 2019–2027 ($MILLION)
TABLE 07.3D CELL CULTURE MARKET FOR GELS, BY REGION, 2019–2027 ($MILLION)
TABLE 08.3D CELL CULTURE MARKET FOR BIOREACTORS, BY REGION, 2019–2027 ($MILLION)
TABLE 09.3D CELL CULTURE MARKET FOR MICROCHIPS, BY REGION, 2019–2027 ($MILLION)
TABLE 10.3D CELL CULTURE MARKET FOR SERVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 11.3D CELL CULTURE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 12.3D CELL CULTURES MARKET FOR CANCER RESEARCH, BY REGION, 2019–2027 ($MILLION)
TABLE 13.3D CELL CULTURE MARKET FOR STEM CELL RESEARCH, BY REGION, 2019–2027 ($MILLION)
TABLE 14.3D CELL CULTURE MARKET FOR DRUG DISCOVERY, BY REGION, 2019–2027 ($MILLION)
TABLE 15.3D CELL CULTURE MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2019–2027 ($MILLION)
TABLE 16.3D CELL CULTURE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 17.3D CELL CULTURE MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2019–2027 ($MILLION)
TABLE 18.3D CELL CULTURE MARKET FOR CONTRACT RESEARCH LABORATORIES, BY REGION, 2019–2027 ($MILLION)
TABLE 19.3D CELL CULTURE MARKET FOR ACADEMIC INSTITUTES, BY REGION, 2019–2027 ($MILLION)
TABLE 20.3D CELL CULTURE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 21.NORTH AMERICA 3D CELL CULTURE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 22.NORTH AMERICA 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 23.NORTH AMERICA 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 24.NORTH AMERICA 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 25.U.S. 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 26.U.S. 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 27.U.S. 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 28.CANADA 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 29.CANADA 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 30.CANADA 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 31.MEXICO 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 32.MEXICO 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 33.MEXICO 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 34.EUROPE 3D CELL CULTURE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 35.EUROPE 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 36.EUROPE 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 37.EUROPE 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 38.GERMANY 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 39.GERMANY 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 40.GERMANY 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 41.FRANCE 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 42.FRANCE 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 43.FRANCE 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 44.UK 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 45.UK 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 46.UK 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 47.REST OF EUROPE 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 48.REST OF EUROPE 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 49.U.S. 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 50.ASIA-PACIFIC 3D CELL CULTURE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 51.ASIA-PACIFIC 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 52.ASIA-PACIFIC 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 53.ASIA-PACIFIC 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 54.JAPAN 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 55.JAPAN 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 56.JAPAN 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 57.CHINA 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 58.CHINA 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 59.CHINA 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 60.INDIA 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 61.INDIA 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 62.INDIA 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 63.AUSTRALIA 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 64.AUSTRALIA 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 65.AUSTRALIA 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 66.REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 67.REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 68.REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 69.LAMEA 3D CELL CULTURE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 70.LAMEA 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 71.LAMEA 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 72.LAMEA 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 73.BRAZIL 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 74.BRAZIL 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 75.BRAZIL 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 76.SAUDI ARABIA 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 77.SAUDI ARABIA 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 78.SAUDI ARABIA 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 79.SOUTH AFRICA 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 80.SOUTH AFRICA 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 81.SOUTH AFRICA 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 82.REST OF LAMEA 3D CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 83.REST OF LAMEA 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 84.REST OF LAMEA 3D CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 85.3D BIOTEK: COMPANY SNAPSHOT
TABLE 86.3D BIOTEK: OPERATING SEGMENTS
TABLE 87.ADVANCED BIOMATRIX: COMPANY SNAPSHOT
TABLE 88.ADVANCED BIOMATRIX: OPERATING SEGMENTS
TABLE 89.AVANTOR: COMPANY SNAPSHOT
TABLE 90.AVANTOR: OPERATING SEGMENTS
TABLE 91.BD: COMPANY SNAPSHOT
TABLE 92.BD: OPERATING SEGMENTS
TABLE 93.CORNING: COMPANY SNAPSHOT
TABLE 94.CORNING: OPERATING SEGMENTS
TABLE 95.INSPHERO: COMPANY SNAPSHOT
TABLE 96.INSPHERO: OPERATING SEGMENTS
TABLE 97.LONZA: COMPANY SNAPSHOT
TABLE 98.LONZA: OPERATING SEGMENTS
TABLE 99.MERCK: COMPANY SNAPSHOT
TABLE 100.MERCK: OPERATING SEGMENTS
TABLE 101.SYNTHECON: COMPANY SNAPSHOT
TABLE 102.THERMO FISHER: COMPANY SNAPSHOT
TABLE 103.THERMO FISHER: OPERATING SEGMENTS
LIST OF FIGURES
FIGURE 01.3D CELL CULTURE MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017–2020*
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENTS, 2017–2020* (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017–2020*
FIGURE 06.PATENTS REGISTERED/ APPROVED, BY YEAR (2011-2020)
FIGURE 07.PATENTS REGISTERED/ APPROVED, BY YEAR (2011-2020)
FIGURE 08.DRIVERS, RESTRAINTS AND OPPORTUNITY
FIGURE 09.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED PLATFORM, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 10.SCAFFOLD-BASED PLATFORM MARKET FOR MACRO-POROUS SCAFFOLDS, 2019 & 2027 ($MILLION)
FIGURE 11.SCAFFOLD-BASED PLATFORM MARKET FOR MICRO-POROUS SCAFFOLDS, 2019 & 2027 ($MILLION)
FIGURE 12.SCAFFOLD-BASED PLATFORM MARKET FOR NANO-POROUS SCAFFOLDS, 2019 & 2027 ($MILLION)
FIGURE 13.SCAFFOLD-BASED PLATFORM MARKET FOR SOLID SCAFFOLDS, 2019 & 2027 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE PLATFORM, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR GELS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR MICROCHIPS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR SERVICES, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR CANCER RESEARCH, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 24.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR CONTRACT RESEARCH LABORATORIES, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 25.COMPARATIVE ANALYSIS OF 3D CELL CULTURE MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 26.CANCER SURVIVOR PREDICTIONS IN U.S.
FIGURE 27.CANCER INCIDENCES IN GERMANY (2007 & 2050)
FIGURE 28.AVANTOR: NET SALES, 2017–2019 ($MILLION)
FIGURE 29.AVANTOR: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 30.AVANTOR: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 31.BD: NET SALES, 2017–2019 ($MILLION)
FIGURE 32.BD: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 33.BD: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 34.CORNING: NET SALES, 2017–2019 ($MILLION)
FIGURE 35.CORNING: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 36.CORNING: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 37.LONZA: NET SALES, 2017–2019 ($MILLION)
FIGURE 38.LONZA: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 39.LONZA: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 40.MERCK: NET SALES, 2017–2019 ($MILLION)
FIGURE 41.MERCK: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 42.MERCK: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 43.THERMO FISHER: NET SALES, 2017–2019 ($MILLION)
FIGURE 44.THERMO FISHER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 45.THERMO FISHER: REVENUE SHARE BY REGION, 2019 (%)
$5769
$8995
Add to Cart
Add to Cart
Add to Cart
Add to Cart